arrow
A

Axel Behrens

The Institute of Cancer Research
H指数:66
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

撤稿注意: 针对内源性逆转录病毒的抗体促进肺癌免疫治疗

Nature
IF48.5
2026-01-140
OAAI
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer

SPP1对于维持胰腺癌的间充质细胞命运是必需的。

Nature
IF48.5
2025-09-240
OA
Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway

更正:PARP1抑制剂与奥沙利铂联合应用,通过同源重组和碱基切除修复通路,高效抑制源自胃癌类器官的奥沙利铂耐药性。

2025-08-290
OA
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Nature
IF48.5
2023-04-120
OAAI
GREM1 is required to maintain cellular heterogeneity in pancreatic cancer
Nature
IF48.5
2022-06-290
PRE